Monday, December 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Vonovia Stock: Strong Recovery Fuels Optimism

Robert Sasse by Robert Sasse
August 6, 2025
in Stocks
0
Vonovia Stock
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

Germany’s largest residential real estate group has reported a robust first-half performance, signaling a turnaround in the property market. Vonovia’s adjusted pre-tax profit surged by 11% to €984 million, while EBITDA rose 12% to €1.42 billion, driven by strong rental growth and strategic sales. The operating free cash flow—critical for dividends—jumped 53% to €1.17 billion, exceeding analyst expectations. Rental income increased 2.6% to €1.69 billion despite a smaller portfolio, with average rents climbing 4.6% to €8.22 per square meter. The vacancy rate dipped to 2.1%, underscoring resilient demand.

Growth Segments Shine

Recurring Sales EBITDA soared 74% to €38.7 million, while the development division swung to a €54 million profit. Value-Add Services nearly doubled EBITDA to €100.7 million. Portfolio valuations rose 1.3%, reflecting market recovery. Vonovia raised its 2025 guidance, targeting adjusted pre-tax profit of €1.85–1.95 billion, up from €1.75–1.85 billion, and confirmed plans to double investments to €2 billion by 2028. Strategic deals, including a €700 million Berlin land transaction, strengthened its balance sheet, with debt easing to 47.3%. The upbeat results suggest sustained momentum ahead.

Ad

Vonovia Stock: Buy or Sell?! New Vonovia Analysis from December 22 delivers the answer:

The latest Vonovia figures speak for themselves: Urgent action needed for Vonovia investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 22.

Vonovia: Buy or sell? Read more here...

Tags: Vonovia
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Eli Lilly Stock
Stocks

Eli Lilly’s Strategic Diversification Amid Weight-Loss Drug Competition

November 18, 2025
Micron Stock
Stocks

Micron Shares Approach Peak: What Comes After the AI Rally?

November 18, 2025
Varonis Stock
Stocks

Varonis Shares Plunge Amidst Mixed Signals

November 18, 2025
Next Post
ABN Amro Stock

ABN Amro Stock: Profit Dip Amid Strong Capital Moves

Beiersdorf Stock

Beiersdorf Stock: Nivea's Glow Fades as Forecasts Dim

Fresenius Stock

Fresenius Stock: Mixed Q2 Results Amid Margin Pressures

Recommended

Redfin Stock

Navigating Market Turbulence: Redfin’s Challenging Real Estate Landscape

3 months ago
MercadoLibre Stock

MercadoLibre’s Strategic Expansion into Brazil’s Pharmaceutical Sector

2 months ago
Orsted Stock

Orsted Stock: Crisis Deepens as $8.8B Rescue Plan Unveiled

4 months ago
Staar Surgical Stock

Boardroom Battle Erupts at Staar Surgical Ahead of Crucial Vote

3 weeks ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Bitcoin Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Fiserv Stock: A Potential Rebound Amidst Institutional Accumulation?

Solana’s Contradiction: Institutional Faith Meets Network Strain

PepsiCo’s Strategic Pivot Meets Investor Skepticism

Adobe Faces Mounting Challenges Despite Strong Earnings

Jabil Shares Surge on Upbeat Guidance and Robust Quarterly Performance

Rolls-Royce Charts Course for Shareholder Returns with New Financial Framework

Trending

LVMH Stock
Analysis

LVMH Shares: A Market in Search of Equilibrium

by Felix Baarz
December 22, 2025
0

The era of unchecked expansion in the global luxury sector appears to be transitioning into a period...

Vulcan Energy Stock

Vulcan Energy Shares Gain Analyst Favor Following Project Milestone

December 22, 2025
Pfizer Stock

Pfizer’s 2026 Midpoint: A Stock Under Pressure Amid Strategic Pivots

December 22, 2025
Fiserv Stock

Fiserv Stock: A Potential Rebound Amidst Institutional Accumulation?

December 22, 2025
Solana Stock

Solana’s Contradiction: Institutional Faith Meets Network Strain

December 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • LVMH Shares: A Market in Search of Equilibrium
  • Vulcan Energy Shares Gain Analyst Favor Following Project Milestone
  • Pfizer’s 2026 Midpoint: A Stock Under Pressure Amid Strategic Pivots

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com